摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,cis)-3-(2-amino-6-chloro-9H-purin-9-ylmethyl)-1,2,2-trimethylcyclopentylmethanol | 168974-91-2

中文名称
——
中文别名
——
英文名称
(1R,cis)-3-(2-amino-6-chloro-9H-purin-9-ylmethyl)-1,2,2-trimethylcyclopentylmethanol
英文别名
[(1R,3S)-3-[(2-amino-6-chloropurin-9-yl)methyl]-1,2,2-trimethylcyclopentyl]methanol
(1R,cis)-3-(2-amino-6-chloro-9H-purin-9-ylmethyl)-1,2,2-trimethylcyclopentylmethanol化学式
CAS
168974-91-2
化学式
C15H22ClN5O
mdl
——
分子量
323.826
InChiKey
OMDWVCNJBDBBFF-PSLIRLAXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    89.8
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1R,cis)-3-(2-amino-6-chloro-9H-purin-9-ylmethyl)-1,2,2-trimethylcyclopentylmethanol 作用下, 以40%的产率得到(1R,cis)-3-(2,6-diamino-9H-purin-9-ylmethyl)-1,2,2-trimethylcyclopentylmethanol
    参考文献:
    名称:
    Carbocyclic Nucleosides with a Modified Cyclopentane Skeleton
    摘要:
    The aminoalcohol 4 has been converted into carbocyclic nucleoside analogues 2 and 3.
    DOI:
    10.1080/15257779508012365
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Antiviral and Cytostatic Activities of Carbocyclic Nucleosides Incorporating a Modified Cyclopentane Ring. I: Guanosine Analogues
    摘要:
    Six new carbocyclic nucleosides were prepared by constructing a guanine (compounds 6, 8 and 10) or 8-azaguanine (compounds 7, 9 and 11) base on the amino group of (1R, cis)-3-(aminomethyl)-1,2,2-trimethylcyclopentylmethanol (2), and their activities against 13 viruses and 3 tumor cell lines were determined. Compounds 9, 10 and 11 showed activity against human immunodeficiency virus type 1 (HIV-1), and compound 11 also against vaccina virus, whereas compounds 6 and 7 showed some inhibition of tumor cell proliferation.
    DOI:
    10.1080/07328319708002530
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Evaluation of Antineoplastic Activity of Novel Carbocyclic Nucleosides
    作者:Aliuska M. Helguera、J. E. Rodríguez-Borges、Olga Caamaño、Xerardo García-Mera、Maykel Pérez González、M. Natália D. S. Cordeiro
    DOI:10.1002/minf.200900033
    日期:2010.3.15
    active or inactive, and only two were false actives, corroborating the good predictive ability of the present discriminant model. The results of this study thus provide a valuable tool for the design of novel potent anticancer nucleoside analogues.
    癌症是85岁以下男女死亡的主要原因。每年,有数百万人被诊断出患有癌症。但是,寻找新药是一项复杂,昂贵且非常耗时的任务。在过去的十年中,癌症研究界已开始解决计算机模拟建模方法,例如定量结构-活性关系(QSAR),作为靶向潜在抗癌药物的重要替代工具。通过在我们的实验室或其他地方合成的大量核苷数据集的汇编,并在相同的实验条件下在单细胞毒性测定中进行了测试,我们认识到了独特的机会来尝试建立预测性QSAR模型。从该数据集的一部分构建的2D分类模型的早期工作非常令人鼓舞。在这里,我们报告对分类模型的进一步详细评估,以标记源自各种3D分子表示形式的潜在抗癌活性。获得了将抗癌化合物与非活性化合物区分开的定量3D模型模型,该模型可以在如此庞大而多样的数据集中正确分类82%的化合物,其中只有5%的错误非活性成分和11%的错误活性成分。通过预先将其分类为活性/非活性抗癌化合物,可将此处开发的模型用于选择和设计一
  • Carbocyclic Nucleosides with a Modified Cyclopentane Skeleton
    作者:O. Caamaño、F. Fernández、G. Gómez、M. I. Nieto
    DOI:10.1080/15257779508012365
    日期:1995.5.1
    The aminoalcohol 4 has been converted into carbocyclic nucleoside analogues 2 and 3.
  • Synthesis and Antiviral and Cytostatic Activities of Carbocyclic Nucleosides Incorporating a Modified Cyclopentane Ring. I: Guanosine Analogues
    作者:J. M. Blanco、O. Caamaño、F. Fernández、G. Gómez、M. I. Nieto、J. Balzarini、E. Padalko、E. De Clercq
    DOI:10.1080/07328319708002530
    日期:1997.1
    Six new carbocyclic nucleosides were prepared by constructing a guanine (compounds 6, 8 and 10) or 8-azaguanine (compounds 7, 9 and 11) base on the amino group of (1R, cis)-3-(aminomethyl)-1,2,2-trimethylcyclopentylmethanol (2), and their activities against 13 viruses and 3 tumor cell lines were determined. Compounds 9, 10 and 11 showed activity against human immunodeficiency virus type 1 (HIV-1), and compound 11 also against vaccina virus, whereas compounds 6 and 7 showed some inhibition of tumor cell proliferation.
查看更多